A company named Cybin has developed a synthetic version of psilocybin, allowing for standardized dosages and easier patenting, unlike its natural counterpart. This innovation could revolutionize the accessibility and consistency of psilocybin use. Additionally, digestive enzymes are highlighted as a beneficial aid for those increasing protein intake, helping to alleviate gastrointestinal issues and improve nutrient absorption.
